A detailed physiologically-based model to simulate the pharmacokinetics and hormonal pharmacodynamics of enalapril on the circulating endocrine renin-angiotensin-aldosterone system

A detailed physiologically-based model to simulate the pharmacokinetics and hormonal pharmacodynamics of enalapril on the circulating endocrine renin-angiotensin-aldosterone system

The renin-angiotensin-aldosterone system (RAAS) plays a key role in the pathogenesis of cardiovascular disorders including hypertension and is one of the most important targets for drugs. A whole body physiologically-based pharmacokinetic (wb PBPK) model integrating this hormone circulation system a...

Full description

Bibliographic Details
Main Authors:	Karina eClaassen, Stefan eWillmann, Thomas eEissing, Tobias ePreusser, Michael eBlock
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2013-02-01
Series:	Frontiers in Physiology
Subjects:	Enalapril Enalaprilat cardiovascular Physiologically-based pharmacokinetic model renin-angiotensin-aldosterone system
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fphys.2013.00004/full

Similar Items

EVOLUTION STAGES OF LOW RENIN HYPERTENSION
by: S. V. Akhadov, et al.
Published: (2016-01-01)

Planning and Evaluation of Bioequivalence Studies of Enalapril Products
by: D. P. Romodanovsk, et al.
Published: (2018-12-01)

Aldosterone-to-renin ratio (ARR) as a screening tool for primary aldosteronism (PA)
by: Chia-Hung Lin, et al.
Published: (2024-03-01)

Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension
by: Fabio Bioletto, et al.
Published: (2023-05-01)

Survey of renin and aldosterone testing practices by Ontario laboratories – Providing insight into best practices
by: Angela C. Rutledge, et al.
Published: (2021-05-01)

RENIN-ANGIOTENSIN PROFILE AND COMPARATIVE EFFECTIVENESS OF FIRST-LINE MEDICATIONS IN MONOTHERAPY OF ESSENTIAL ARTERIAL HYPERTENSION
by: Sh. V. Akhadov, et al.
Published: (2010-06-01)

Heightened Cardiovascular Risk in Hypertension Associated With Renin‐Independent Aldosteronism Versus Renin‐Dependent Aldosteronism: A Collaborative Study
by: Jinbo Hu, et al.
Published: (2021-12-01)

Completing the Enalaprilat Excretion Pathway—Renal Handling by the Proximal Tubule
by: Nori J. L. Smeets, et al.
Published: (2020-09-01)

Quantitative Value of Aldosterone‐Renin Ratio for Detection of Aldosterone‐Producing Adenoma: The Aldosterone‐Renin Ratio for Primary Aldosteronism (AQUARR) Study
by: Giuseppe Maiolino, et al.
Published: (2017-05-01)

Capacities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system
by: M L Maksimov
Published: (2010-06-01)

The state of renin-aldosterone system in patients with resistant arterial hypertension
by: О. H. Оbertynska
Published: (2019-06-01)

The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma
by: Kazuyuki Hirooka, et al.
Published: (2022-03-01)

The effect of medication on the aldosterone‐to‐renin ratio. A critical review of the literature
by: Rawan M. Alnazer, et al.
Published: (2021-02-01)

The Effect of Antihypertensive Medications on Testing for Primary Aldosteronism
by: Piotr Jędrusik, et al.
Published: (2021-05-01)

Dynamic changes of renin-angiotensin-aldosterone system parameters after surgery of primary hyperparathyroidism
by: E. A. Dobreva, et al.
Published: (2020-11-01)

Comparison of the Chemiluminescence Immunoassay LIAISON® with the Radioimmunoassay for Aldosterone and Renin Measurement
by: Jana Uhrová, et al.
Published: (2021-06-01)

The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone
by: Ming-Hui Zheng, et al.
Published: (2020-08-01)

Patients with pheochromocytoma exhibit low aldosterone renin ratio-preliminary reports
by: Tomoko Yamada, et al.
Published: (2020-09-01)

Effect of sodium–glucose cotransporter-2 inhibitors on aldosterone-to-renin ratio in diabetic patients with hypertension: a retrospective observational study
by: Toshitaka Sawamura, et al.
Published: (2020-11-01)

Effect of calcifediol supplementation on renin‐angiotensin‐aldosterone system mediators in dogs with chronic kidney disease
by: Matthew Miller, et al.
Published: (2022-09-01)

Implications of Plasma Renin Activity and Plasma Aldosterone Concentration in Critically Ill Patients with Septic Shock
by: Kyung Soo Chung, et al.
Published: (2017-05-01)

Regulation of the renin-angiotensin-aldosterone system by cyclic nucleotides and phosphodiesterases
by: Stepan Gambaryan, et al.
Published: (2023-08-01)

Arterial hypertension in hypothyrosis: severity and state of renin-aldosteron system
by: G. B. Selivanova, et al.
Published: (2004-06-01)

Activation of the renin-angiotensin-aldosterone system in mares around ovulation
by: Katy Satué, et al.
Published: (2017-06-01)

How to potentialize the effect of renin-angiotensin-aldosterone system inhibitors?
by: D.D. Ivanov
Published: (2021-09-01)

Prevalence of aldosterone breakthrough in dogs receiving renin‐angiotensin system inhibitors for proteinuric chronic kidney disease
by: Marisa K. Ames, et al.
Published: (2022-11-01)

Adiposity, aldosterone and plasma renin activity among African Americans: The Jackson Heart Study
by: Grace Lee, et al.
Published: (2023-06-01)

Diet‐induced prediabetes: Effects on the activity of the renin–angiotensin–aldosterone system in selected organs
by: Bongeka Cassandra Mkhize, et al.
Published: (2022-05-01)

Diagnostic Role of Captopril Challenge Test in Korean Subjects with High Aldosterone-to-Renin Ratios
by: Jung Hee Kim, et al.
Published: (2016-06-01)

Confounders of the aldosterone‐to‐renin ratio when used as a screening test in hypertensive patients: A critical analysis of the literature
by: Gregory P. Veldhuizen, et al.
Published: (2021-02-01)

Clinical determinants and prognostic implications of renin and aldosterone in patients with symptomatic heart failure
by: Masatake Kobayashi, et al.
Published: (2020-06-01)

First Trimester Renin and Aldosterone Levels of Pregnant Women With Prognosis of Preeclampsia and/or Related Adverse Pregnancy Outcomes
by: Yunus Emre Purut, et al.
Published: (2017-06-01)

The activity of the renin-angiotensin-aldosterone system before and after parathyroidectomy in patients with primary hyperparathyroidism
by: Liubov G. Yanevskaya, et al.
Published: (2021-12-01)

Left ventricular hypertrophy and renin-angiotensin-aldosterone system: AT1-receptor blockers are in the focus
by: A V Barsukov, et al.
Published: (2013-03-01)

Diagnosis and management of primary aldosteronism
by: Leticia A. P. Vilela, et al.

Pênfigo vegetante induzido por uso de enalapril Pemphigus vegetans induced by use of enalapril
by: André Ricardo Adriano, et al.
Published: (2011-12-01)

The functional state of the kallikrein-kinin and renin-angiotensin-aldosterone systems in patients with localized kidney cancer
by: N. D. Ushakova, et al.
Published: (2021-12-01)

Enalapril: Synthesis and properties
by: Mijin Dušan Ž., et al.
Published: (2004-01-01)

The influence of renin angiotensin aldosterone system blockers on asymmetric dimethylarginine levels in patients with chronic glomerulonephritis
by: Heleniak Zbigniew, et al.
Published: (2016-12-01)

Who needs to be screened for primary aldosteronism?
by: Wei-Chieh Huang, et al.
Published: (2024-03-01)